Previous Article | Next Article 
Journal of Bacteriology, August 1999, p. 4669-4672, Vol. 181, No. 15
Center for Adaptation Genetics and Drug
Resistance,1 and Departments of
Molecular Biology and Microbiology2 and
Medicine,3 Tufts University School of
Medicine, Boston, Massachusetts 02111
Received 30 December 1998/Accepted 28 May 1999
MarR negatively regulates expression of the multiple antibiotic
resistance operon (marRAB) in Escherichia coli.
In this study, it was demonstrated that sodium salicylate, plumbagin,
2,4-dinitrophenol, and menadione-inducers of the marRAB
operon in whole cells-all interfered with the repressor activity of
MarR in vitro. It is proposed that these compounds can interact
directly with MarR to affect its repressor activity.
The multiple antibiotic resistance
locus (mar) of Escherichia coli controls
intrinsic susceptibility to multiple antibiotics, organic solvents,
oxidative stress agents, and household disinfectants (3,
19). In E. coli and Salmonella
typhimurium the mar locus is organized into two
divergently positioned transcriptional units, marC and
marRAB, whose expression is under the control of a centrally located promoter and operator region, marO (5,
28). In the absence of an appropriate stimulus, MarR negatively
regulates expression of the marRAB operon (5) by
binding to two regions, sites I and II (15), within
marO. MarR repression is alleviated following exposure to a
variety of diverse compounds (4, 6, 8, 15, 25).
Previous experiments in vitro demonstrated that radiolabeled
salicylic acid bound MarR with a Kd of 0.5 mM,
and sodium salicylate inhibited the formation of
MarR-marO complexes as judged by a gel retardation assay
(15). Although some evidence for tetracycline binding to
MarR (Kd > 10 mM) was also demonstrated, these
earlier studies did not detect any effect of tetracycline,
chloramphenicol, or other structurally different chemicals on MarR
function (15).
MarR is a member of a newly recognized family of regulatory proteins,
many of which may interact with phenolic compounds
(29). Two MarR homologs, Ec17kd and MprA (EmrR), when
expressed from plasmids, negatively regulated expression of a
marOR-lacZ fusion (29), and the repressor
function of both proteins in whole cells was antagonized by salicylate
(12, 29). CinR, the MarR homolog from Butyrivibrio
fibrisolvens E14, is antagonized in vitro by two compounds that
contain ferrulic acid, a cinnamic acid (salicylate-like compound in
plants) derivative (7).
In this study, a restriction enzyme site protection assay was used to
test the abilities of different chemicals to interfere with a
MarR-marO interaction in vitro. The basis of the assay was
plasmid pSup-Test, which contains two SspI sites: one within marO at 913 bp and the other elsewhere on the plasmid at
4,385 bp (Fig. 1). Wild-type MarR was
specified by pMarR-WT, a medium-copy-number high-level wild-type MarR
expression vector (2) constructed in pET13a (27),
a kanamycin-resistant version of pET11a (Novagen, Madison, Wis.).
0021-9193/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Alteration of the Repressor Activity of MarR, the Negative
Regulator of the Escherichia coli marRAB Locus, by
Multiple Chemicals In Vitro
ABSTRACT
Top
Abstract
Text
References
TEXT
Top
Abstract
Text
References
View larger version (12K):
[in a new window]
FIG. 1.
Map of plasmid pSup-Test showing the positions of the
SspI sites within the plasmid.
MarR was purified from E. coli BL21(DE3) (Novagen)
containing pMarR-WT essentially as described previously (2).
Frozen cell pellets (2 g) were lysed in 8 ml of buffer P (100 mM sodium phosphate [pH 7.4] containing 0.5 ml of a protease inhibitor cocktail [Sigma, St. Louis, Mo.]), ion-exchange chromatography on
sulfopropyl-Sepharose HiTrap columns (Pharmacia Biotech,
Piscataway, N.J.) was performed in 10 mM sodium phosphate (pH 7.4), and
the purified protein was dialyzed against 333 volumes of a
solution containing 50 mM Tris-HCl (pH 7.4), 100 mM NaCl, 10%
glycerol, and 1 mM phenylmethylsulfonyl fluoride (serine protease
inhibitor) overnight at 4°C. Samples of the purified MarR, judged to
be >99% pure on a sodium dodecyl sulfate-polyacrylamide gel
electrophoresis Coomassie blue-stained gel, were stored at 
70°C
until further use.
Analysis of MarR function in vitro. Reaction mixtures were prepared as previously described (2). A single linearly cut plasmid (4,576 bp) indicated that MarR protected the SspI site within site I of marO and that the second SspI site at 4,385 bp in pSup-Test was accessible to digestion (Fig. 2, lane L, fragment A). The production of two smaller fragments, of 3,472 and 1,104 bp, indicated that the SspI recognition sequence within site I of marO was no longer protected (Fig. 2, lane D, fragments B and C).
|
1 to 5 nM) (15,
25). We estimated the affinity of MarR for marO by
determining the point of 50% protection, judged by the visual
inspection of ethidium bromide-stained gels (9, 18, 26).
Consistently, average ~Kds of 2.1 and 0.95 µM (assuming the monomeric and dimeric forms of MarR, respectively) were obtained (Fig. 2). However, these values do not represent true
Kd values for many reasons. Both competition
between MarR and the restriction endonuclease and the continual
depletion of the amount of target DNA (marO) due to the
restriction enzyme contribute to an underestimation of the true
Kd. Although nonspecific protein-nucleic acid
interactions have been observed for other bacterial transcription
factors (9), nonspecific binding for MarR was not evident,
since the nonoperator SspI recognition sequence was
accessible at the highest protein concentrations tested (Fig. 2, last
two lanes). In these experiments, the off-rate for the MarR-marO interaction must be sufficiently low in order to
protect marO from cleavage. This assay measures the presence
of MarR on site I only (see reference 3 for a review
regarding DNA-protein interactions at marO). However, since
sites I and II are separated by a very short distance, it is
anticipated, as observed for other prokaryotic transcription factors,
that protein-protein communication among repressors at these sites
would exist. The major advantage of the restriction enzyme site
protection assay over a standard gel shift assay is that it is
performed at equilibrium.
Effects of many chemicals on MarR repressor activity. The restriction enzyme site protection assays were performed in the presence of various inducers to determine if any of these chemicals could antagonize repressor function directly in vitro. SspI digestion of pSup-Test in the presence of the various marRAB operon inducers and control compounds showed no effect on the activity of the restriction endonuclease (data not shown). These chemicals were then tested for their effect on the DNA binding activity of MarR in vitro (Fig. 3A, B, and C). Sodium salicylate, at a concentration of 2 mM, interfered with the DNA binding activity of MarR (Fig. 3A, lane 5), and this effect was more pronounced at higher concentrations (Fig. 3A, lane 6).
|
mar background in E. coli, this induction
appeared to be independent of the mar locus (24).
Another group found that paraquat at a much higher concentration (1.3 mM) induced the expression of a marO-lacZ fusion 2.7-fold in
a wild-type host and 0.98-fold in a mar background
(25). Thus, at high amounts paraquat affected mar
expression (25). The results found in vitro suggest that paraquat at high concentrations induces expression of the
marRAB operon by an indirect mechanism.
Plumbagin, an oxidative stress agent, and 2,4-dinitrophenol, an
uncoupler, were the most effective compounds tested with visible deprotection at 250 µM (Fig. 3C, lanes 4 and 7). Menadione caused deprotection at 800 µM (Fig. 3C, lane 10).
In the in vitro assays, ampicillin at a concentration of 5 mM appeared
to antagonize the DNA binding activity of MarR (data not shown).
However, unlike that of other active agents, this effect was not
observed at lower concentrations, i.e., 1 or 2.5 mM (data not shown).
Ampicillin does not induce marRAB expression in whole cells
(8). Since this finding may have resulted from its being
kept out of the cell by the AcrAB multidrug efflux system (21,
22), we tested its ability to induce mar in E. coli AG100A (22), which has AcrAB deleted. No MarA
expression was detected (with MarA polyclonal antibodies
[16]) despite exposure to 2 mg of ampicillin per ml
(data not shown). These results suggest that ampicillin's effect at
high concentrations in vitro is nonspecific.
No effect on MarR repressor activity was detected with chloramphenicol
and norfloxacin at 5 mM, but a slight deprotection was observed when
the chloramphenicol concentration was increased to ~10 mM (data not
shown). In previous experiments, only a marginal level of binding
(Kd > 10 mM) of MarR to tetracycline was seen, but tetracycline had no effect on nucleoprotein complexes
(15). It is therefore probable that the induction of
marRAB expression in whole cells by chloramphenicol and
tetracycline (8) occurs indirectly. An
unidentified cellular product generated upon exposure to
either of these compounds may function as the inducer
(3). Alternatively, both antibiotics may simply increase
mRNA stability (13).
The relatively high inducer concentrations in these assays correlate
with their activities in whole cells (8). A specificity is
evident from the lack of activity by other compounds but leaves open
the possibility that an intrinsic cell-mediated inducer exists, which
has not been identified (3). Still, the variety of
structures that cause induction in vitro suggest that MarR has a
broadly specific, low-affinity substrate binding site.
Experiments in which MarR was added to pSup-Test before the
inducer produced results identical to those described above (data not shown). These findings suggest that compounds which induce marRAB expression can interact with MarR whether it is bound
to DNA or free. In both instances this interaction altered the DNA binding activity of the repressor.
The low background level of ethidium bromide staining seen with some
samples is attributed to two factors: the intrinsic fluorescence of the
inducers under UV light and the formation of unique nucleoprotein complexes. Purified MarR forms multimers (15, 25) which are seen on sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels
containing 8 M urea (data not shown). The background staining seen in
samples containing MarR, but not with plasmid alone, may represent
different multimeric forms of MarR complexed with DNA.
Conclusions.
The findings in this report provide evidence that
multiple structurally unrelated chemicals (inducers) interfere directly with MarR function in vitro. The multidrug binding profiles of efflux
proteins have been demonstrated (11, 20, 23). Fewer examples
of multidrug binding to cytoplasmic proteins have been reported. BmrR,
the positive regulator of the Bacillus subtilis Bmr
multidrug transporter, binds rhodamine 6G (Kd 1 µM [14]) and tetraphenylphosphonium
(Kd 100 µM [14]), which
are also substrates of the pump (1, 30). The gene product of
fabI in E. coli, encoding enoyl reductase, binds
natural fatty acid substrates with high affinity and interacts with at
least two different chemicals, triclosan and diazaborine, that inhibit
the function of the protein (10, 17). By responding with
different affinities to many unrelated chemicals, MarR is well adapted
to control the cell's rapid response to multiple environmental hazards.
| |
ACKNOWLEDGMENTS |
|---|
We are grateful to Laura McMurry, Michael Malamy, Bruce Demple, and the excellent reviewers for their thoughtful and helpful comments on the manuscript.
This work was supported by NIH grant GM 51661.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Center for Adaptation Genetics and Drug Resistance, Tufts University School of Medicine, 136 Harrison Ave., Boston, MA 02111. Phone: (617) 636-6764. Fax: (617) 636-0458. E-mail: slevy{at}opal.tufts.edu.
| |
REFERENCES |
|---|
|
Top
Abstract
Text
References
|
|---|
| 1. |
Ahmed, M.,
C. M. Borsch,
S. S. Taylor,
N. Vazquez-Laslop, and A. A. Neyfakh.
1994.
A protein that activates expression of a multidrug efflux transporter upon binding the transporter substrates.
J. Biol. Chem.
269:28506-28513 |
| 2. |
Alekshun, M. N., and S. B. Levy.
1999.
Characterization of MarR superrepressor mutants.
J. Bacteriol.
181:3303-3306 |
| 3. | Alekshun, M. N., and S. B. Levy. 1997. Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon. Antimicrob. Agents Chemother. 41:2067-2075[Medline]. |
| 4. |
Ariza, R. R.,
S. P. Cohen,
N. Bachhawat,
S. B. Levy, and B. Demple.
1994.
Repressor mutations in the marRAB operon that activate oxidative stress genes and multiple antibiotic resistance in Escherichia coli.
J. Bacteriol.
176:143-148 |
| 5. |
Cohen, S. P.,
H. Hächler, and S. B. Levy.
1993.
Genetic and functional analysis of the multiple antibiotic resistance (mar) locus in Escherichia coli.
J. Bacteriol.
175:1484-1492 |
| 6. |
Cohen, S. P.,
S. B. Levy,
J. Foulds, and J. L. Rosner.
1993.
Salicylate induction of antibiotic resistance in Escherichia coli: activation of the mar operon and a mar-independent pathway.
J. Bacteriol.
175:7856-7862 |
| 7. |
Dalrymple, B. P., and Y. Swadling.
1997.
Expression of a Butyrivibrio fibrisolvens E14 gene (cinB) encoding an enzyme with cinnamoyl ester hydrolase activity is negatively regulated by the product of an adjacent gene (cinR).
Microbiology
143:1203-1210 |
| 8. |
Hächler, H.,
S. P. Cohen, and S. B. Levy.
1991.
marA, a regulated locus which controls expression of chromosomal multiple antibiotic resistance in Escherichia coli.
J. Bacteriol.
173:5532-5538 |
| 9. |
Joachimiak, A.,
R. L. Kelley,
R. P. Gunsalus,
C. Yanofsky, and P. B. Sigler.
1983.
Purification and characterization of trp aporepressor.
Proc. Natl. Acad. Sci. USA
80:668-672 |
| 10. | Levy, C. W., A. Roujeinikova, S. Sedelnikova, P. J. Baker, A. R. Stuitje, A. R. Slabas, D. W. Rice, and J. B. Rafferty. 1999. Molecular basis of triclosan activity. Nature 398:383-384[Medline]. |
| 11. | Lewis, K. 1994. Multidrug resistance pumps in bacteria: variations on a theme. Trends Biochem. Sci. 19:119-123[Medline]. |
| 12. |
Lomovskaya, O.,
K. Lewis, and A. Matin.
1995.
EmrR is a negative regulator of the Escherichia coli multidrug resistance pump EmrAB.
J. Bacteriol.
177:2328-2334 |
| 13. |
Lopez, P. J.,
I. Marchand,
O. Yarchuk, and M. Dreyfus.
1998.
Translation inhibitors stabilize Escherichia coli mRNAs independently of ribosome protection.
Proc. Natl. Acad. Sci. USA
95:6067-6072 |
| 14. | Markham, P. N., J. LoGuidice, and A. Neyfakh. 1997. Broad ligand specificity of the transcriptional regulator of the Bacillus subtilis multidrug transporter Bmr. Biochem. Biophys. Res. Commun. 239:269-272[Medline]. |
| 15. |
Martin, R. G., and J. L. Rosner.
1995.
Binding of purified multiple antibiotic-resistance repressor protein (MarR) to mar operator sequences.
Proc. Natl. Acad. Sci. USA
92:5456-5460 |
| 16. |
McDermott, P. F.,
D. G. White,
I. Podglajen,
M. N. Alekshun, and S. B. Levy.
1998.
Multidrug resistance following expression of the Escherichia coli marA gene in Mycobacterium smegmatis.
J. Bacteriol.
180:2995-2998 |
| 17. | McMurry, L. M., M. Oethinger, and S. B. Levy. 1998. Triclosan targets lipid synthesis. Nature 394:531-532[Medline]. |
| 18. |
Melville, S. B., and R. P. Gunsalus.
1996.
Isolation of an oxygen-sensitive FNR protein of Escherichia coli: interaction at activator and repressor sites of FNR-controlled genes.
Proc. Natl. Acad. Sci. USA
93:1226-1231 |
| 19. | Moken, M. C., L. M. McMurry, and S. B. Levy. 1997. Selection of multiple-antibiotic-resistant (Mar) mutants of Escherichia coli by using the disinfectant pine oil: roles of the mar and acrAB loci. Antimicrob. Agents Chemother. 41:2770-2772[Abstract]. |
| 20. |
Nikaido, H.
1996.
Multidrug efflux pumps of gram-negative bacteria.
J. Bacteriol.
178:5853-5859 |
| 21. |
Nikaido, H.,
M. Basina,
V. Nguyen, and E. Y. Rosenberg.
1998.
Multidrug efflux pump AcrAB of Salmonella typhimurium excretes only those  -lactam antibiotics containing lipophilic side chains.
J. Bacteriol.
180:4686-4692 |
| 22. |
Okusu, H.,
D. Ma, and H. Nikaido.
1996.
AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants.
J. Bacteriol.
178:306-308 |
| 23. |
Paulsen, I. T.,
M. H. Brown, and R. A. Skurray.
1996.
Proton-dependent multidrug efflux systems.
Microbiol. Rev.
60:575-608 |
| 24. |
Rosner, J. L., and J. L. Slonczewski.
1994.
Dual regulation of inaA by the multiple antibiotic resistance (mar) and superoxide (soxRS) stress response systems of Escherichia coli.
J. Bacteriol.
176:6262-6269 |
| 25. |
Seoane, A. S., and S. B. Levy.
1995.
Characterization of MarR, the repressor of the multiple antibiotic resistance (mar) operon of Escherichia coli.
J. Bacteriol.
177:3414-3419 |
| 26. |
Smith, H. Q., and R. L. Somerville.
1997.
The tpl promoter of Citrobacter freundii is activated by the TyrR protein.
J. Bacteriol.
179:5914-5921 |
| 27. | Studier, F. W., A. H. Rosenberg, J. J. Dunn, and J. W. Dubendorff. 1990. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol. 185:60-89[Medline]. |
| 28. |
Sulavik, M. C.,
M. Dazer, and P. F. Miller.
1997.
The Salmonella typhimurium mar locus: molecular and genetic analyses and assessment of its requirement for virulence.
J. Bacteriol.
179:1857-1866 |
| 29. | Sulavik, M. C., L. F. Gambino, and P. F. Miller. 1995. The MarR repressor of the multiple antibiotic resistance (mar) operon in Escherichia coli: prototypic member of a family of bacterial regulatory proteins involved in sensing phenolic compounds. Mol. Med. 1:436-446[Medline]. |
| 30. | Zheleznova, E. E., P. N. Markham, A. A. Neyfakh, and R. G. Brennan. 1999. Structural basis of multidrug recognition by BmrR, a transcription activator of a multidrug transporter. Cell 96:353-362[Medline]. |
Journal of Bacteriology, August 1999, p. 4669-4672, Vol. 181, No. 15
0021-9193/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Wang, S., Deng, K., Zaremba, S., Deng, X., Lin, C., Wang, Q., Tortorello, M. L., Zhang, W.
(2009). Transcriptomic Response of Escherichia coli O157:H7 to Oxidative Stress. Appl. Environ. Microbiol.
75: 6110-6123
[Abstract] [Full Text] -
Rosner, J. L., Martin, R. G.
(2009). An Excretory Function for the Escherichia coli Outer Membrane Pore TolC: Upregulation of marA and soxS Transcription and Rob Activity Due to Metabolites Accumulated in tolC Mutants. J. Bacteriol.
191: 5283-5292
[Abstract] [Full Text] -
Kumarevel, T., Tanaka, T., Umehara, T., Yokoyama, S.
(2009). ST1710-DNA complex crystal structure reveals the DNA binding mechanism of the MarR family of regulators. Nucleic Acids Res
37: 4723-4735
[Abstract] [Full Text] -
Zhang, Y.-M., Rock, C. O.
(2009). Transcriptional regulation in bacterial membrane lipid synthesis. J. Lipid Res.
50: S115-S119
[Abstract] [Full Text] -
McDermott, P. F., McMurry, L. M., Podglajen, I., Dzink-Fox, J. L., Schneiders, T., Draper, M. P., Levy, S. B.
(2008). The marC Gene of Escherichia coli Is Not Involved in Multiple Antibiotic Resistance. Antimicrob. Agents Chemother.
52: 382-383
[Full Text] -
Daigle, D. M., Cao, L., Fraud, S., Wilke, M. S., Pacey, A., Klinoski, R., Strynadka, N. C., Dean, C. R., Poole, K.
(2007). Protein Modulator of Multidrug Efflux Gene Expression in Pseudomonas aeruginosa. J. Bacteriol.
189: 5441-5451
[Abstract] [Full Text] -
Nicoloff, H., Perreten, V., Levy, S. B.
(2007). Increased Genome Instability in Escherichia coli lon Mutants: Relation to Emergence of Multiple-Antibiotic-Resistant (Mar) Mutants Caused by Insertion Sequence Elements and Large Tandem Genomic Amplifications. Antimicrob. Agents Chemother.
51: 1293-1303
[Abstract] [Full Text] -
Yoshida, M., Oikawa, T., Obata, H., Abe, K., Mihara, H., Esaki, N.
(2007). Biochemical and Genetic Analysis of the {gamma}-Resorcylate (2,6-Dihydroxybenzoate) Catabolic Pathway in Rhizobium sp. Strain MTP-10005: Identification and Functional Analysis of Its Gene Cluster. J. Bacteriol.
189: 1573-1581
[Abstract] [Full Text] -
McMahon, M. A. S., Xu, J., Moore, J. E., Blair, I. S., McDowell, D. A.
(2007). Environmental Stress and Antibiotic Resistance in Food-Related Pathogens. Appl. Environ. Microbiol.
73: 211-217
[Abstract] [Full Text] -
Nicoloff, H., Perreten, V., McMurry, L. M., Levy, S. B.
(2006). Role for Tandem Duplication and Lon Protease in AcrAB-TolC- Dependent Multiple Antibiotic Resistance (Mar) in an Escherichia coli Mutant without Mutations in marRAB or acrRAB.. J. Bacteriol.
188: 4413-4423
[Abstract] [Full Text] -
Chen, J.-W., Sun, C.-M., Sheng, W.-L., Wang, Y.-C., Syu, W.-J.
(2006). Expression Analysis of Up-Regulated Genes Responding to Plumbagin in Escherichia coli. J. Bacteriol.
188: 456-463
[Abstract] [Full Text] -
Tran, H. J., Heroven, A. K., Winkler, L., Spreter, T., Beatrix, B., Dersch, P.
(2005). Analysis of RovA, a Transcriptional Regulator of Yersinia pseudotuberculosis Virulence That Acts through Antirepression and Direct Transcriptional Activation. J. Biol. Chem.
280: 42423-42432
[Abstract] [Full Text] -
Perez-Reinado, E., Blasco, R., Castillo, F., Moreno-Vivian, C., Roldan, M. D.
(2005). Regulation and Characterization of Two Nitroreductase Genes, nprA and nprB, of Rhodobacter capsulatus. Appl. Environ. Microbiol.
71: 7643-7649
[Abstract] [Full Text] -
Ramos, J. L., Martinez-Bueno, M., Molina-Henares, A. J., Teran, W., Watanabe, K., Zhang, X., Gallegos, M. T., Brennan, R., Tobes, R.
(2005). The TetR Family of Transcriptional Repressors. Microbiol. Mol. Biol. Rev.
69: 326-356
[Abstract] [Full Text] -
Wilkinson, S. P., Grove, A.
(2004). HucR, a Novel Uric Acid-responsive Member of the MarR Family of Transcriptional Regulators from Deinococcus radiodurans. J. Biol. Chem.
279: 51442-51450
[Abstract] [Full Text] -
McCallum, N., Bischoff, M., Maki, H., Wada, A., Berger-Bachi, B.
(2004). TcaR, a Putative MarR-Like Regulator of sarS Expression. J. Bacteriol.
186: 2966-2972
[Abstract] [Full Text] -
Schneiders, T., Amyes, S. G. B., Levy, S. B.
(2003). Role of AcrR and RamA in Fluoroquinolone Resistance in Clinical Klebsiella pneumoniae Isolates from Singapore. Antimicrob. Agents Chemother.
47: 2831-2837
[Abstract] [Full Text] -
Gayet, S., Chollet, R., Molle, G., Pages, J.-M., Chevalier, J.
(2003). Modification of Outer Membrane Protein Profile and Evidence Suggesting an Active Drug Pump in Enterobacter aerogenes Clinical Strains. Antimicrob. Agents Chemother.
47: 1555-1559
[Abstract] [Full Text] -
Bina, X., Perreten, V., Levy, S. B.
(2003). The Periplasmic Protein MppA Requires an Additional Mutated Locus To Repress marA Expression in Escherichia coli. J. Bacteriol.
185: 1465-1469
[Abstract] [Full Text] -
Grkovic, S., Brown, M. H., Skurray, R. A.
(2002). Regulation of Bacterial Drug Export Systems. Microbiol. Mol. Biol. Rev.
66: 671-701
[Abstract] [Full Text] -
Godsey, M. H., Zheleznova Heldwein, E. E., Brennan, R. G.
(2002). Structural Biology of Bacterial Multidrug Resistance Gene Regulators. J. Biol. Chem.
277: 40169-40172
[Full Text] -
Lim, D., Poole, K., Strynadka, N. C. J.
(2002). Crystal Structure of the MexR Repressor of the mexRAB-oprM Multidrug Efflux Operon of Pseudomonas aeruginosa. J. Biol. Chem.
277: 29253-29259
[Abstract] [Full Text] -
Baranova, N., Nikaido, H.
(2002). The BaeSR Two-Component Regulatory System Activates Transcription of the yegMNOB (mdtABCD) Transporter Gene Cluster in Escherichia coli and Increases Its Resistance to Novobiocin and Deoxycholate. J. Bacteriol.
184: 4168-4176
[Abstract] [Full Text] -
Helling, R. B., Janes, B. K., Kimball, H., Tran, T., Bundesmann, M., Check, P., Phelan, D., Miller, C.
(2002). Toxic Waste Disposal in Escherichia coli. J. Bacteriol.
184: 3699-3703
[Abstract] [Full Text] -
Providenti, M. A., Wyndham, R. C.
(2001). Identification and Functional Characterization of CbaR, a MarR-Like Modulator of the cbaABC-Encoded Chlorobenzoate Catabolism Pathway. Appl. Environ. Microbiol.
67: 3530-3541
[Abstract] [Full Text] -
Pomposiello, P. J., Bennik, M. H. J., Demple, B.
(2001). Genome-Wide Transcriptional Profiling of the Escherichia coli Responses to Superoxide Stress and Sodium Salicylate. J. Bacteriol.
183: 3890-3902
[Abstract] [Full Text] -
Balagué, C., Véscovi, E. G.
(2001). Activation of Multiple Antibiotic Resistance in Uropathogenic Escherichia coli Strains by Aryloxoalcanoic Acid Compounds. Antimicrob. Agents Chemother.
45: 1815-1822
[Abstract] [Full Text] -
Barthelmebs, L., Diviès, C., Cavin, J.-F.
(2001). Expression in Escherichia coli of Native and Chimeric Phenolic Acid Decarboxylases with Modified Enzymatic Activities and Method for Screening Recombinant E. coli Strains Expressing These Enzymes. Appl. Environ. Microbiol.
67: 1063-1069
[Abstract] [Full Text] -
Barbosa, T. M., Levy, S. B.
(2000). Differential Expression of over 60 Chromosomal Genes in Escherichia coli by Constitutive Expression of MarA. J. Bacteriol.
182: 3467-3474
[Abstract] [Full Text]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»